UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032433
Receipt number R000036985
Scientific Title The Evaluation of Efficacy and Safety of Radiofrequency Ablation and Cryoballoon Ablation in Patients with Atrial Fibrillation and Left Ventricular Dysfunction, Randomized Singlecenter Clinical Trial
Date of disclosure of the study information 2018/05/01
Last modified on 2022/11/01 10:24:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Evaluation of Efficacy and Safety of Radiofrequency Ablation and Cryoballoon Ablation in Patients with Atrial Fibrillation and Left Ventricular Dysfunction, Randomized Singlecenter Clinical Trial

Acronym

RF and Cryo Ablation of AF in Patients with LV dysfunction

Scientific Title

The Evaluation of Efficacy and Safety of Radiofrequency Ablation and Cryoballoon Ablation in Patients with Atrial Fibrillation and Left Ventricular Dysfunction, Randomized Singlecenter Clinical Trial

Scientific Title:Acronym

RF and Cryo Ablation of AF in Patients with LV dysfunction

Region

Japan


Condition

Condition

Atrial Fibrillation

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of RF ablation and cryoablation of AF in patients with LV dysfunction

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. recurrence rate of atrial tachyarrhythmia 1 year after ablation
2. composite of all-cause mortality or worsening of heart failure requiring unplanned hospitalization

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

cryoballoon ablation

Interventions/Control_2

RF ablation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Atrial fibrillation
2. Reduced LV contraction

Key exclusion criteria

1. Prior history of catheter ablation and/or surgery for atrial fibrillation
2. Normal LV contraction
3. Left atrial dimension more than 55 mm
4. Common pulmonary vein
5. Pregnant

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Kengo
Middle name
Last name Kusano

Organization

National Cerebral and Cardiovascular Center

Division name

Division of Arrhythmia and Electrophysiology, Department of Cardiovascular Medicine

Zip code

564-8565

Address

6-1, Kishibeshimmachi, Suita, Osaka

TEL

06-6170-1070

Email

kusanokengo@gmail.com


Public contact

Name of contact person

1st name Koji
Middle name
Last name Miyamoto

Organization

National Cerebral and Cardiovascular Center

Division name

Division of Arrhythmia and Electrophysiology, Department of Cardiovascular Medicine

Zip code

564-8565

Address

6-1, Kishibeshimmachi, Suita, Osaka

TEL

06-6170-1070

Homepage URL


Email

koji3koji3@gmail.com


Sponsor or person

Institute

Division of Arrhythmia and Electrophysiology, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center

Institute

Department

Personal name



Funding Source

Organization

Basic Research Program of National Cerebral and Cardiovascular Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, National Cerebral and Cardiovascular Center

Address

6-1, Kishibeshinmachi, Suita, Osaka

Tel

06-6170-1070

Email

rec-office-ac@ncvc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 04 Month 25 Day

Date of IRB

2018 Year 04 Month 25 Day

Anticipated trial start date

2018 Year 05 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 04 Month 30 Day

Last modified on

2022 Year 11 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036985


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name